by Jordana Choucair | May 6, 2022 | Payers
Centene announced it plans to divest two of its pharmacy businesses for a total of $2.8 billion. The insurer will sell its Magellan Rx subsidiary to Prime Therapeutics, a pharmacy benefit manger (PBM) backed by some of the country’s largest Blues plans, and will...
by Jordana Choucair | May 6, 2022 | Payers
In the wake of the leaked Supreme Court opinion that would overturn Roe v. Wade, employers are contemplating measures to help employees access abortion services. Thus far, at least 12 companies have expressed a commitment to employees’ rights: Amazon, Alloy, Apple,...
by Jordana Choucair | May 5, 2022 | Life Sciences
The House Energy and Commerce Committee released a user fee authorization bill that would allow regulators to revoke approval for drugs cleared through the accelerated approval program if drugmakers delay their required follow-up trials. A stronger measure from an...
by Jordana Choucair | May 5, 2022 | Life Sciences
Johnson & Johnson (J&J) filed a lawsuit Wednesday accusing pharmacy benefit manager SaveOnSP of improperly exploiting J&J’s copay assistance program, called Janssen CarePath, that pays out-of-pocket costs for patients who use some of the company’s...
by Jordana Choucair | May 5, 2022 | Mental Health
Mental telehealth startup Cerebral said it will stop prescribing Adderall and other controlled substances to treat attention deficit hyperactivity disorder for new patients. The decision came after Cerebral’s preferred pharmacy, Truepill, said it would halt...
Recent Comments